Aprea Therapeutics, Inc. (APRE)
0.8386
-0.02
(-2.50%)
USD |
NASDAQ |
Aug 28, 16:00
0.8361
0.00 (0.00%)
After-Hours: 20:00
Aprea Therapeutics Free Cash Flow : -12.31M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -12.31M |
| March 31, 2026 | -12.57M |
| December 31, 2025 | -13.44M |
| September 30, 2025 | -13.55M |
| June 30, 2025 | -12.91M |
| March 31, 2025 | -12.98M |
| December 31, 2024 | -13.29M |
| September 30, 2024 | -13.99M |
| June 30, 2024 | -13.54M |
| March 31, 2024 | -13.18M |
| December 31, 2023 | -12.21M |
| September 30, 2023 | -12.38M |
| Date | Value |
|---|---|
| June 30, 2023 | -15.74M |
| March 31, 2023 | -21.08M |
| December 31, 2022 | -23.60M |
| September 30, 2022 | -29.10M |
| June 30, 2022 | -31.27M |
| March 31, 2022 | -30.48M |
| December 31, 2021 | -36.51M |
| September 30, 2021 | -41.32M |
| June 30, 2021 | -46.78M |
| March 31, 2021 | -48.68M |
| December 31, 2020 | -44.71M |
| September 30, 2020 | -40.80M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Zymeworks, Inc. | -120.53M |
| Rhythm Pharmaceuticals, Inc. | -146.30M |
| Onconetix, Inc. | -10.31M |
| ACADIA Pharmaceuticals, Inc. | 145.62M |
| Alnylam Pharmaceuticals, Inc. | 793.94M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.206M |
| Cash from Investing (Quarterly) | -0.0152M |
| Cash from Financing (Quarterly) | -2.334M |
| Free Cash Flow Per Share (Quarterly) | -0.0602 |
| Free Cash Flow to Equity (Quarterly) | -3.221M |
| Free Cash Flow to Firm (Quarterly) | -3.221M |
| Free Cash Flow Yield | -71.42% |